Figure 2
From: Serum anti-CFL1, anti-EZR, and anti-CYPA autoantibody as diagnostic markers in ovarian cancer
Performance of the five anti-TAA autoantibodies in the discovery cohort. (a, c, e, g, i) Scatter plots and (b, d, f, h, j) receiver operating characteristic curve (ROC) for five anti-TAA autoantibodies in the discovery cohort. The longest line means median, and the 25th and 75th percentiles are represented by shorter lines.
